Summary:
Evaluation of the effect of benralizumab on COPD exacerbations in subjects with moderate to very severe COPD.
Qualified Participants Must:
• Have COPD
•
Be between 40 and 85 years of age
•
Have a history of tobacco use
Qualified Participants May Receive:
Coverage for current COPD medications and compensation for participation